Stephanie Byrum
Concepts (491)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 29 | 2023 | 343 | 5.400 |
Why?
| Proteome | 18 | 2024 | 178 | 3.450 |
Why?
| Histones | 16 | 2023 | 335 | 2.670 |
Why?
| Chromatin | 12 | 2023 | 156 | 2.000 |
Why?
| Mass Spectrometry | 16 | 2024 | 313 | 1.800 |
Why?
| Protein Processing, Post-Translational | 9 | 2021 | 183 | 1.690 |
Why?
| Protein Interaction Mapping | 3 | 2020 | 44 | 1.330 |
Why?
| Saccharomyces cerevisiae Proteins | 9 | 2019 | 170 | 1.270 |
Why?
| Saccharomyces cerevisiae | 9 | 2019 | 218 | 1.140 |
Why?
| Bacterial Proteins | 5 | 2020 | 454 | 1.000 |
Why?
| Mice | 40 | 2024 | 6413 | 0.990 |
Why?
| Chromosomal Proteins, Non-Histone | 5 | 2021 | 44 | 0.970 |
Why?
| Animals | 52 | 2024 | 14385 | 0.950 |
Why?
| Transcriptome | 5 | 2022 | 346 | 0.920 |
Why?
| Polycomb-Group Proteins | 2 | 2021 | 9 | 0.920 |
Why?
| Staphylococcus aureus | 4 | 2020 | 361 | 0.890 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2023 | 67 | 0.890 |
Why?
| Melanoma | 6 | 2024 | 313 | 0.880 |
Why?
| Peptide Hydrolases | 2 | 2020 | 67 | 0.830 |
Why?
| Computational Biology | 2 | 2020 | 231 | 0.800 |
Why?
| Signal Transduction | 7 | 2022 | 1753 | 0.800 |
Why?
| Genomics | 2 | 2021 | 310 | 0.780 |
Why?
| Phosphoproteins | 1 | 2020 | 116 | 0.700 |
Why?
| DNA Methylation | 4 | 2023 | 574 | 0.700 |
Why?
| Endothelial Cells | 6 | 2023 | 294 | 0.670 |
Why?
| Trichloroethylene | 1 | 2019 | 73 | 0.660 |
Why?
| Binding Sites | 1 | 2019 | 440 | 0.650 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2019 | 180 | 0.630 |
Why?
| Environmental Exposure | 1 | 2019 | 205 | 0.620 |
Why?
| Software | 1 | 2020 | 296 | 0.620 |
Why?
| Blood Proteins | 1 | 2017 | 100 | 0.580 |
Why?
| Protein Binding | 8 | 2021 | 736 | 0.580 |
Why?
| Whole-Body Irradiation | 1 | 2017 | 160 | 0.550 |
Why?
| Chromatography, Affinity | 2 | 2012 | 50 | 0.540 |
Why?
| Space Flight | 3 | 2020 | 37 | 0.520 |
Why?
| Chemical Fractionation | 1 | 2015 | 18 | 0.520 |
Why?
| Bone Neoplasms | 3 | 2013 | 193 | 0.480 |
Why?
| MicroRNAs | 3 | 2023 | 386 | 0.460 |
Why?
| Humans | 49 | 2024 | 54284 | 0.450 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 151 | 0.450 |
Why?
| Epigenesis, Genetic | 7 | 2023 | 399 | 0.440 |
Why?
| Chromatin Immunoprecipitation | 1 | 2012 | 55 | 0.430 |
Why?
| Gene Expression Regulation, Neoplastic | 7 | 2021 | 866 | 0.430 |
Why?
| Nevus, Pigmented | 2 | 2012 | 37 | 0.430 |
Why?
| Methionine | 2 | 2024 | 146 | 0.400 |
Why?
| Cluster Analysis | 3 | 2023 | 249 | 0.400 |
Why?
| Cell Line, Tumor | 9 | 2024 | 1550 | 0.400 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2021 | 39 | 0.400 |
Why?
| Skin Neoplasms | 2 | 2020 | 532 | 0.390 |
Why?
| Lysine | 3 | 2023 | 102 | 0.390 |
Why?
| Transcription Factors | 6 | 2021 | 622 | 0.390 |
Why?
| Virulence | 4 | 2020 | 194 | 0.380 |
Why?
| DNA-Binding Proteins | 4 | 2021 | 462 | 0.380 |
Why?
| Gene Silencing | 3 | 2023 | 129 | 0.370 |
Why?
| Genetic Loci | 3 | 2015 | 58 | 0.360 |
Why?
| Colonic Neoplasms | 2 | 2022 | 164 | 0.360 |
Why?
| Cyclophosphamide | 2 | 2021 | 172 | 0.360 |
Why?
| Osteosarcoma | 1 | 2010 | 37 | 0.360 |
Why?
| Galactokinase | 3 | 2015 | 10 | 0.360 |
Why?
| Methylation | 5 | 2023 | 130 | 0.360 |
Why?
| CTLA-4 Antigen | 2 | 2021 | 29 | 0.360 |
Why?
| Melanoma, Experimental | 2 | 2021 | 49 | 0.350 |
Why?
| Gene Expression Profiling | 8 | 2023 | 1138 | 0.350 |
Why?
| Histone Code | 2 | 2021 | 32 | 0.350 |
Why?
| Virulence Factors | 3 | 2020 | 92 | 0.350 |
Why?
| Trans-Activators | 2 | 2020 | 147 | 0.340 |
Why?
| Protein Kinase Inhibitors | 2 | 2021 | 216 | 0.340 |
Why?
| Mitochondria | 3 | 2023 | 489 | 0.340 |
Why?
| Doxorubicin | 2 | 2021 | 259 | 0.340 |
Why?
| Nerve Tissue Proteins | 2 | 2021 | 199 | 0.330 |
Why?
| Multiple Myeloma | 4 | 2023 | 3035 | 0.330 |
Why?
| Hippocampus | 2 | 2020 | 242 | 0.320 |
Why?
| Mice, Inbred C57BL | 10 | 2023 | 1999 | 0.320 |
Why?
| Neoplasms | 4 | 2021 | 1316 | 0.310 |
Why?
| Breast Neoplasms | 5 | 2024 | 1248 | 0.310 |
Why?
| Cell Proliferation | 7 | 2023 | 1096 | 0.310 |
Why?
| Drug Resistance, Neoplasm | 2 | 2020 | 309 | 0.300 |
Why?
| Osteomyelitis | 2 | 2019 | 122 | 0.290 |
Why?
| Diet | 2 | 2021 | 598 | 0.290 |
Why?
| HEK293 Cells | 7 | 2021 | 245 | 0.280 |
Why?
| Fungal Proteins | 2 | 2020 | 134 | 0.280 |
Why?
| RNA | 2 | 2024 | 202 | 0.280 |
Why?
| Tumor Microenvironment | 3 | 2021 | 209 | 0.270 |
Why?
| Organoids | 2 | 2023 | 41 | 0.260 |
Why?
| Lung Neoplasms | 2 | 2024 | 642 | 0.260 |
Why?
| Mutation | 7 | 2020 | 1501 | 0.260 |
Why?
| Co-Repressor Proteins | 2 | 2023 | 17 | 0.260 |
Why?
| RNA-Binding Proteins | 3 | 2021 | 136 | 0.260 |
Why?
| Gene Expression Regulation, Bacterial | 4 | 2020 | 244 | 0.250 |
Why?
| Disease Models, Animal | 5 | 2021 | 1639 | 0.250 |
Why?
| Proteolysis | 2 | 2022 | 102 | 0.250 |
Why?
| Male | 19 | 2023 | 27334 | 0.250 |
Why?
| Cell Line | 4 | 2023 | 1153 | 0.240 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2022 | 99 | 0.240 |
Why?
| Female | 20 | 2024 | 28441 | 0.240 |
Why?
| Cell Cycle Proteins | 3 | 2021 | 199 | 0.240 |
Why?
| Chiroptera | 1 | 2023 | 6 | 0.240 |
Why?
| Retroelements | 1 | 2023 | 15 | 0.240 |
Why?
| Endogenous Retroviruses | 1 | 2023 | 7 | 0.240 |
Why?
| Mediator Complex | 1 | 2023 | 5 | 0.240 |
Why?
| Interferon Type I | 1 | 2023 | 30 | 0.230 |
Why?
| Viruses | 1 | 2023 | 21 | 0.230 |
Why?
| Gonadotrophs | 1 | 2023 | 22 | 0.230 |
Why?
| Cyclin-Dependent Kinases | 1 | 2023 | 35 | 0.230 |
Why?
| Osteoclasts | 3 | 2022 | 469 | 0.230 |
Why?
| Leishmania | 1 | 2023 | 7 | 0.230 |
Why?
| Formaldehyde | 2 | 2015 | 49 | 0.230 |
Why?
| Bovine Respiratory Disease Complex | 1 | 2023 | 1 | 0.230 |
Why?
| Electrophoresis, Capillary | 1 | 2023 | 16 | 0.230 |
Why?
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 74 | 0.230 |
Why?
| Cattle Diseases | 1 | 2023 | 8 | 0.230 |
Why?
| Lymphoma | 1 | 2024 | 72 | 0.230 |
Why?
| Oxidative Stress | 4 | 2023 | 958 | 0.230 |
Why?
| Leishmaniasis, Cutaneous | 1 | 2023 | 17 | 0.230 |
Why?
| Biofilms | 3 | 2020 | 200 | 0.220 |
Why?
| Amines | 1 | 2023 | 46 | 0.220 |
Why?
| Neuroendocrine Tumors | 1 | 2023 | 28 | 0.220 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2023 | 27 | 0.220 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 9 | 0.220 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 106 | 0.220 |
Why?
| Respiratory Tract Diseases | 1 | 2023 | 29 | 0.220 |
Why?
| Milk, Human | 2 | 2021 | 109 | 0.220 |
Why?
| Gastrointestinal Neoplasms | 1 | 2023 | 46 | 0.220 |
Why?
| Peripheral Nerve Injuries | 1 | 2022 | 26 | 0.220 |
Why?
| Ikaros Transcription Factor | 1 | 2022 | 6 | 0.220 |
Why?
| Cecum | 2 | 2021 | 72 | 0.220 |
Why?
| Weightlessness | 2 | 2020 | 14 | 0.220 |
Why?
| Leishmania major | 1 | 2022 | 11 | 0.220 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2022 | 4 | 0.220 |
Why?
| Staphylococcal Infections | 3 | 2020 | 300 | 0.210 |
Why?
| Immunotherapy | 2 | 2021 | 263 | 0.210 |
Why?
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 108 | 0.210 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 164 | 0.210 |
Why?
| Diet, High-Fat | 1 | 2023 | 216 | 0.210 |
Why?
| Liver Failure, Acute | 1 | 2022 | 64 | 0.200 |
Why?
| Nuclear Pore Complex Proteins | 1 | 2021 | 9 | 0.200 |
Why?
| End Stage Liver Disease | 1 | 2022 | 43 | 0.200 |
Why?
| Promoter Regions, Genetic | 3 | 2019 | 520 | 0.200 |
Why?
| Phosphofructokinase-1, Type C | 1 | 2021 | 4 | 0.200 |
Why?
| YY1 Transcription Factor | 1 | 2021 | 7 | 0.200 |
Why?
| Tandem Mass Spectrometry | 2 | 2023 | 248 | 0.200 |
Why?
| Molecular Chaperones | 2 | 2020 | 64 | 0.200 |
Why?
| Activating Transcription Factor 4 | 1 | 2021 | 5 | 0.200 |
Why?
| Spectrum Analysis, Raman | 1 | 2021 | 68 | 0.200 |
Why?
| Uterine Artery | 1 | 2021 | 3 | 0.200 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2022 | 131 | 0.200 |
Why?
| Cadherins | 2 | 2019 | 72 | 0.200 |
Why?
| Transcription Factor Pit-1 | 1 | 2021 | 15 | 0.200 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2021 | 21 | 0.200 |
Why?
| Ozone | 1 | 2021 | 19 | 0.200 |
Why?
| Pituitary Gland, Anterior | 1 | 2021 | 28 | 0.200 |
Why?
| Cysteine | 1 | 2021 | 62 | 0.190 |
Why?
| Homeodomain Proteins | 1 | 2021 | 82 | 0.190 |
Why?
| Radiation, Ionizing | 1 | 2022 | 120 | 0.190 |
Why?
| Epigenomics | 1 | 2021 | 67 | 0.190 |
Why?
| Septins | 1 | 2020 | 19 | 0.190 |
Why?
| Cryptococcus neoformans | 1 | 2020 | 28 | 0.190 |
Why?
| Carcinoma, Hepatocellular | 1 | 2023 | 203 | 0.190 |
Why?
| Milk Substitutes | 1 | 2020 | 6 | 0.190 |
Why?
| T-Lymphocytes | 2 | 2020 | 373 | 0.190 |
Why?
| Cranial Irradiation | 1 | 2020 | 24 | 0.190 |
Why?
| NF-E2-Related Factor 2 | 1 | 2021 | 63 | 0.190 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 101 | 0.190 |
Why?
| Blood-Brain Barrier | 1 | 2020 | 59 | 0.190 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 132 | 0.190 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 62 | 0.190 |
Why?
| Chlamydia trachomatis | 1 | 2020 | 42 | 0.190 |
Why?
| Amino Acid Motifs | 1 | 2020 | 57 | 0.190 |
Why?
| Metalloporphyrins | 1 | 2020 | 13 | 0.190 |
Why?
| Cervix Uteri | 1 | 2020 | 53 | 0.190 |
Why?
| Workflow | 1 | 2020 | 57 | 0.180 |
Why?
| Social Behavior | 1 | 2020 | 85 | 0.180 |
Why?
| Up-Regulation | 3 | 2018 | 508 | 0.180 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 115 | 0.180 |
Why?
| Infant Formula | 1 | 2021 | 152 | 0.180 |
Why?
| Neovascularization, Pathologic | 1 | 2021 | 168 | 0.180 |
Why?
| Osteogenesis Imperfecta | 1 | 2020 | 39 | 0.180 |
Why?
| Extracellular Matrix Proteins | 1 | 2020 | 75 | 0.180 |
Why?
| Memory | 1 | 2020 | 124 | 0.180 |
Why?
| Databases, Genetic | 1 | 2020 | 101 | 0.180 |
Why?
| DNA Breaks, Double-Stranded | 2 | 2017 | 78 | 0.180 |
Why?
| Adaptation, Ocular | 1 | 2019 | 4 | 0.180 |
Why?
| Insulin Resistance | 1 | 2022 | 300 | 0.180 |
Why?
| Blood-Retinal Barrier | 1 | 2019 | 6 | 0.180 |
Why?
| Immunologic Memory | 1 | 2019 | 32 | 0.180 |
Why?
| Poly(A)-Binding Proteins | 1 | 2019 | 6 | 0.180 |
Why?
| Paclitaxel | 1 | 2020 | 103 | 0.180 |
Why?
| Ribonucleoproteins | 1 | 2019 | 20 | 0.180 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 206 | 0.180 |
Why?
| Translocation, Genetic | 1 | 2021 | 287 | 0.170 |
Why?
| Collagen Type I | 1 | 2020 | 97 | 0.170 |
Why?
| Liver Neoplasms | 1 | 2023 | 352 | 0.170 |
Why?
| CpG Islands | 1 | 2019 | 104 | 0.170 |
Why?
| Xenopus Proteins | 1 | 2019 | 29 | 0.170 |
Why?
| Ruminococcus | 1 | 2019 | 9 | 0.170 |
Why?
| Neoplasm Proteins | 2 | 2012 | 359 | 0.170 |
Why?
| Integrin alpha Chains | 1 | 2019 | 10 | 0.170 |
Why?
| Protein Kinases | 1 | 2019 | 89 | 0.170 |
Why?
| Bone Resorption | 1 | 2022 | 326 | 0.170 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2021 | 191 | 0.170 |
Why?
| Behavior, Animal | 1 | 2020 | 200 | 0.170 |
Why?
| Arsenic | 1 | 2019 | 21 | 0.170 |
Why?
| Chlamydia Infections | 1 | 2020 | 119 | 0.170 |
Why?
| Gravity, Altered | 1 | 2018 | 3 | 0.170 |
Why?
| Colorectal Neoplasms | 1 | 2022 | 236 | 0.170 |
Why?
| Cell Cycle Checkpoints | 1 | 2019 | 35 | 0.170 |
Why?
| Profilins | 1 | 2018 | 18 | 0.170 |
Why?
| Starch | 1 | 2019 | 33 | 0.170 |
Why?
| Oxidation-Reduction | 1 | 2020 | 382 | 0.160 |
Why?
| Quality Indicators, Health Care | 1 | 2019 | 99 | 0.160 |
Why?
| Accidental Falls | 1 | 2019 | 98 | 0.160 |
Why?
| Retina | 1 | 2018 | 64 | 0.160 |
Why?
| Chromans | 1 | 2018 | 62 | 0.160 |
Why?
| Gene Expression Regulation | 2 | 2013 | 1062 | 0.160 |
Why?
| Obesity | 2 | 2023 | 1202 | 0.160 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 1056 | 0.160 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 64 | 0.160 |
Why?
| Neurodegenerative Diseases | 1 | 2018 | 83 | 0.150 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 88 | 0.150 |
Why?
| Nuclear Proteins | 2 | 2017 | 252 | 0.150 |
Why?
| Antigens, CD | 1 | 2019 | 242 | 0.150 |
Why?
| Spleen | 1 | 2018 | 186 | 0.150 |
Why?
| Models, Biological | 2 | 2012 | 823 | 0.150 |
Why?
| Cells, Cultured | 3 | 2021 | 1737 | 0.150 |
Why?
| Vitamin E | 1 | 2018 | 107 | 0.150 |
Why?
| Disease Progression | 4 | 2023 | 913 | 0.150 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 124 | 0.150 |
Why?
| Cognition | 1 | 2020 | 348 | 0.150 |
Why?
| Muscle Development | 2 | 2014 | 25 | 0.150 |
Why?
| Cell Differentiation | 5 | 2021 | 720 | 0.150 |
Why?
| Macaca mulatta | 1 | 2017 | 106 | 0.150 |
Why?
| Algorithms | 1 | 2021 | 697 | 0.150 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2017 | 40 | 0.150 |
Why?
| Gamma Rays | 1 | 2017 | 56 | 0.150 |
Why?
| Neurogenesis | 3 | 2022 | 30 | 0.150 |
Why?
| Brain Neoplasms | 1 | 2020 | 284 | 0.150 |
Why?
| Myogenin | 2 | 2014 | 6 | 0.150 |
Why?
| Butadienes | 1 | 2017 | 50 | 0.140 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2017 | 204 | 0.140 |
Why?
| Nucleosomes | 2 | 2013 | 22 | 0.140 |
Why?
| Apoptosis | 5 | 2021 | 1300 | 0.140 |
Why?
| Mitochondria, Liver | 1 | 2017 | 86 | 0.140 |
Why?
| Radiation Injuries | 1 | 2018 | 153 | 0.140 |
Why?
| Animals, Newborn | 3 | 2023 | 396 | 0.140 |
Why?
| Cytochrome P-450 CYP2E1 | 1 | 2017 | 105 | 0.140 |
Why?
| Mice, Inbred BALB C | 3 | 2021 | 368 | 0.140 |
Why?
| Adenine | 1 | 2016 | 44 | 0.140 |
Why?
| Antineoplastic Agents | 2 | 2022 | 1300 | 0.140 |
Why?
| Tumor Burden | 1 | 2016 | 142 | 0.140 |
Why?
| Rhadinovirus | 1 | 2015 | 15 | 0.140 |
Why?
| Chromatography, Liquid | 2 | 2020 | 243 | 0.140 |
Why?
| Brain | 2 | 2023 | 1387 | 0.140 |
Why?
| Renal Insufficiency, Chronic | 1 | 2019 | 182 | 0.130 |
Why?
| Antigens, Viral | 1 | 2015 | 58 | 0.130 |
Why?
| Carcinogens | 1 | 2017 | 231 | 0.130 |
Why?
| Acetylation | 3 | 2021 | 99 | 0.130 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 206 | 0.130 |
Why?
| Homologous Recombination | 1 | 2015 | 43 | 0.130 |
Why?
| Virus Replication | 1 | 2015 | 143 | 0.130 |
Why?
| Histone Acetyltransferases | 1 | 2014 | 22 | 0.120 |
Why?
| Cell Culture Techniques | 1 | 2015 | 112 | 0.120 |
Why?
| Host-Pathogen Interactions | 1 | 2015 | 143 | 0.120 |
Why?
| Rhabdomyosarcoma | 1 | 2014 | 13 | 0.120 |
Why?
| T-Box Domain Proteins | 1 | 2014 | 14 | 0.120 |
Why?
| Threonine | 1 | 2013 | 17 | 0.120 |
Why?
| Megakaryocytes | 1 | 2013 | 23 | 0.120 |
Why?
| Mitosis | 1 | 2013 | 106 | 0.110 |
Why?
| Protein Biosynthesis | 3 | 2023 | 273 | 0.110 |
Why?
| Tumor Cells, Cultured | 3 | 2021 | 477 | 0.110 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2013 | 24 | 0.110 |
Why?
| Eukaryotic Initiation Factor-2 | 2 | 2023 | 18 | 0.110 |
Why?
| Time Factors | 2 | 2017 | 3213 | 0.110 |
Why?
| Sarcoma | 1 | 2014 | 73 | 0.110 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2012 | 9 | 0.110 |
Why?
| Chromosomes, Fungal | 1 | 2012 | 17 | 0.110 |
Why?
| Serotonin | 1 | 2013 | 159 | 0.110 |
Why?
| Mice, Knockout | 3 | 2021 | 926 | 0.110 |
Why?
| DNA Repair Enzymes | 1 | 2012 | 50 | 0.110 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 562 | 0.110 |
Why?
| Homocysteine | 2 | 2024 | 126 | 0.100 |
Why?
| Neoadjuvant Therapy | 2 | 2024 | 125 | 0.100 |
Why?
| gp100 Melanoma Antigen | 1 | 2011 | 9 | 0.100 |
Why?
| Fixatives | 1 | 2011 | 13 | 0.100 |
Why?
| Immunohistochemistry | 2 | 2013 | 1089 | 0.100 |
Why?
| Tissue Fixation | 1 | 2011 | 35 | 0.100 |
Why?
| Paraffin Embedding | 1 | 2011 | 56 | 0.100 |
Why?
| High-Throughput Screening Assays | 1 | 2011 | 37 | 0.100 |
Why?
| Phosphorylation | 3 | 2023 | 614 | 0.100 |
Why?
| Weight Gain | 2 | 2023 | 243 | 0.100 |
Why?
| Oncogene Proteins, Fusion | 2 | 2021 | 60 | 0.100 |
Why?
| Transcriptional Activation | 2 | 2021 | 134 | 0.100 |
Why?
| Heat-Shock Response | 2 | 2020 | 29 | 0.090 |
Why?
| Models, Animal | 2 | 2021 | 255 | 0.090 |
Why?
| Chromosome Positioning | 1 | 2009 | 2 | 0.090 |
Why?
| DNA | 2 | 2024 | 581 | 0.090 |
Why?
| Swine | 2 | 2021 | 431 | 0.090 |
Why?
| DNA Copy Number Variations | 2 | 2022 | 114 | 0.090 |
Why?
| DNA Repair | 3 | 2017 | 202 | 0.090 |
Why?
| Lung | 2 | 2023 | 507 | 0.090 |
Why?
| Prostatic Neoplasms | 2 | 2010 | 415 | 0.080 |
Why?
| Mice, SCID | 2 | 2021 | 196 | 0.080 |
Why?
| Enhancer Elements, Genetic | 2 | 2021 | 64 | 0.080 |
Why?
| Mice, Transgenic | 2 | 2021 | 656 | 0.080 |
Why?
| Radiation-Protective Agents | 2 | 2020 | 116 | 0.080 |
Why?
| Chromatin Assembly and Disassembly | 2 | 2021 | 27 | 0.080 |
Why?
| RNA, Messenger | 2 | 2023 | 1202 | 0.080 |
Why?
| Rats, Sprague-Dawley | 2 | 2021 | 1663 | 0.070 |
Why?
| Osteoblasts | 2 | 2020 | 514 | 0.070 |
Why?
| Cell Cycle | 2 | 2019 | 275 | 0.070 |
Why?
| Phenotype | 2 | 2020 | 820 | 0.070 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2019 | 58 | 0.060 |
Why?
| Jamaica | 1 | 2023 | 9 | 0.060 |
Why?
| Terminal Repeat Sequences | 1 | 2023 | 10 | 0.060 |
Why?
| S-Adenosylmethionine | 1 | 2024 | 56 | 0.060 |
Why?
| Axilla | 1 | 2024 | 101 | 0.060 |
Why?
| Transfection | 2 | 2016 | 399 | 0.060 |
Why?
| MyoD Protein | 2 | 2014 | 11 | 0.060 |
Why?
| Follicle Stimulating Hormone | 1 | 2023 | 26 | 0.060 |
Why?
| Hepatitis B virus | 1 | 2023 | 24 | 0.060 |
Why?
| Microvessels | 1 | 2023 | 34 | 0.060 |
Why?
| Histone Deacetylases | 1 | 2023 | 47 | 0.060 |
Why?
| Integrin beta Chains | 1 | 2023 | 14 | 0.060 |
Why?
| Genome | 1 | 2023 | 74 | 0.060 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2024 | 127 | 0.060 |
Why?
| Integrins | 1 | 2023 | 36 | 0.060 |
Why?
| Sural Nerve | 1 | 2022 | 7 | 0.060 |
Why?
| Lymph Node Excision | 1 | 2024 | 140 | 0.060 |
Why?
| Rats | 2 | 2021 | 3415 | 0.060 |
Why?
| Cytogenetic Analysis | 1 | 2023 | 90 | 0.060 |
Why?
| Nerve Regeneration | 1 | 2022 | 24 | 0.060 |
Why?
| Lymphatic Metastasis | 1 | 2024 | 256 | 0.060 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2023 | 96 | 0.060 |
Why?
| Dogs | 1 | 2023 | 217 | 0.050 |
Why?
| Peripheral Nerves | 1 | 2022 | 51 | 0.050 |
Why?
| Cattle | 1 | 2023 | 224 | 0.050 |
Why?
| Amino Acid Sequence | 2 | 2014 | 767 | 0.050 |
Why?
| L-Lactate Dehydrogenase | 1 | 2022 | 79 | 0.050 |
Why?
| Molecular Sequence Data | 2 | 2014 | 980 | 0.050 |
Why?
| Antiviral Agents | 1 | 2023 | 188 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 51 | 0.050 |
Why?
| Sirtuin 3 | 1 | 2022 | 17 | 0.050 |
Why?
| Hepatocytes | 1 | 2023 | 214 | 0.050 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 133 | 0.050 |
Why?
| Lymph Nodes | 1 | 2024 | 284 | 0.050 |
Why?
| Colonoscopy | 1 | 2022 | 105 | 0.050 |
Why?
| Glycoproteins | 1 | 2022 | 132 | 0.050 |
Why?
| Protein Structure, Tertiary | 2 | 2014 | 289 | 0.050 |
Why?
| Carrier Proteins | 1 | 2023 | 359 | 0.050 |
Why?
| NF-kappa B | 1 | 2023 | 335 | 0.050 |
Why?
| Mice, 129 Strain | 1 | 2021 | 49 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 208 | 0.050 |
Why?
| Mutagenesis, Site-Directed | 1 | 2021 | 117 | 0.050 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2021 | 36 | 0.050 |
Why?
| NIH 3T3 Cells | 1 | 2021 | 55 | 0.050 |
Why?
| Neoplasm Staging | 1 | 2024 | 806 | 0.050 |
Why?
| Registries | 1 | 2024 | 553 | 0.050 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2021 | 50 | 0.050 |
Why?
| Cryptococcosis | 1 | 2020 | 21 | 0.050 |
Why?
| Asymptomatic Infections | 1 | 2020 | 6 | 0.050 |
Why?
| Glycolysis | 1 | 2021 | 73 | 0.050 |
Why?
| Cell Lineage | 1 | 2021 | 93 | 0.050 |
Why?
| Protein Stability | 1 | 2020 | 44 | 0.050 |
Why?
| Chemotherapy, Adjuvant | 1 | 2021 | 119 | 0.050 |
Why?
| rac1 GTP-Binding Protein | 1 | 2020 | 12 | 0.050 |
Why?
| Dendritic Spines | 1 | 2020 | 21 | 0.050 |
Why?
| Somatotrophs | 1 | 2021 | 38 | 0.050 |
Why?
| Sirtuins | 1 | 2020 | 12 | 0.050 |
Why?
| Immunity, Cellular | 1 | 2020 | 80 | 0.050 |
Why?
| GTP Phosphohydrolases | 1 | 2020 | 35 | 0.050 |
Why?
| Lipid Peroxidation | 1 | 2021 | 132 | 0.050 |
Why?
| Early Detection of Cancer | 1 | 2022 | 162 | 0.050 |
Why?
| HeLa Cells | 1 | 2021 | 291 | 0.050 |
Why?
| Bacterial Toxins | 1 | 2020 | 61 | 0.050 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2021 | 151 | 0.050 |
Why?
| Genome, Human | 1 | 2021 | 131 | 0.050 |
Why?
| Dentate Gyrus | 1 | 2020 | 17 | 0.050 |
Why?
| Metalloendopeptidases | 1 | 2020 | 82 | 0.050 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2020 | 219 | 0.050 |
Why?
| Biological Transport | 1 | 2020 | 195 | 0.050 |
Why?
| Macrophages | 1 | 2023 | 405 | 0.050 |
Why?
| Drug Discovery | 1 | 2020 | 90 | 0.050 |
Why?
| CA1 Region, Hippocampal | 1 | 2020 | 28 | 0.050 |
Why?
| Neoplastic Stem Cells | 1 | 2021 | 103 | 0.050 |
Why?
| Radiotherapy | 1 | 2021 | 138 | 0.050 |
Why?
| Cell Transformation, Neoplastic | 1 | 2021 | 200 | 0.040 |
Why?
| Oncology Service, Hospital | 1 | 2019 | 14 | 0.040 |
Why?
| Poly(A)-Binding Protein I | 1 | 2019 | 6 | 0.040 |
Why?
| Zonula Occludens-1 Protein | 1 | 2019 | 7 | 0.040 |
Why?
| Oogenesis | 1 | 2019 | 17 | 0.040 |
Why?
| Stem Cells | 1 | 2021 | 193 | 0.040 |
Why?
| Aquaporin 4 | 1 | 2019 | 9 | 0.040 |
Why?
| Crystallins | 1 | 2019 | 9 | 0.040 |
Why?
| Polyadenylation | 1 | 2019 | 21 | 0.040 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2019 | 37 | 0.040 |
Why?
| Skin | 1 | 2023 | 469 | 0.040 |
Why?
| Arsenate Reductases | 1 | 2019 | 5 | 0.040 |
Why?
| Insulin | 1 | 2022 | 510 | 0.040 |
Why?
| Xenopus laevis | 1 | 2019 | 49 | 0.040 |
Why?
| Placenta | 1 | 2021 | 135 | 0.040 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 16 | 0.040 |
Why?
| Bacteria | 1 | 2021 | 258 | 0.040 |
Why?
| Eye Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| Hematopoietic Stem Cells | 1 | 2021 | 215 | 0.040 |
Why?
| Geriatrics | 1 | 2019 | 47 | 0.040 |
Why?
| Membrane Transport Proteins | 1 | 2019 | 57 | 0.040 |
Why?
| Oocytes | 1 | 2019 | 94 | 0.040 |
Why?
| Motor Neurons | 1 | 2018 | 31 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2019 | 89 | 0.040 |
Why?
| Acetaminophen | 1 | 2022 | 349 | 0.040 |
Why?
| Actin Cytoskeleton | 1 | 2018 | 26 | 0.040 |
Why?
| Mass Screening | 1 | 2022 | 370 | 0.040 |
Why?
| Retinal Pigment Epithelium | 1 | 2018 | 24 | 0.040 |
Why?
| Neuroglia | 1 | 2018 | 52 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2022 | 1084 | 0.040 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 116 | 0.040 |
Why?
| Protein Phosphatase 2 | 1 | 2017 | 6 | 0.040 |
Why?
| Membrane Proteins | 1 | 2020 | 389 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2018 | 107 | 0.040 |
Why?
| Spinal Cord | 1 | 2018 | 151 | 0.040 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 206 | 0.040 |
Why?
| Wnt Signaling Pathway | 1 | 2018 | 94 | 0.040 |
Why?
| Pilot Projects | 1 | 2020 | 808 | 0.040 |
Why?
| Antioxidants | 1 | 2020 | 297 | 0.040 |
Why?
| Repressor Proteins | 1 | 2019 | 165 | 0.040 |
Why?
| Prospective Studies | 1 | 2024 | 2604 | 0.040 |
Why?
| Aging | 1 | 2023 | 784 | 0.040 |
Why?
| Electron Transport Complex III | 1 | 2017 | 12 | 0.040 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 28 | 0.040 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 45 | 0.040 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2017 | 53 | 0.040 |
Why?
| Quality Improvement | 1 | 2019 | 245 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 1 | 2020 | 1476 | 0.040 |
Why?
| Electron Transport Complex I | 1 | 2017 | 42 | 0.040 |
Why?
| Thiolester Hydrolases | 1 | 2016 | 7 | 0.040 |
Why?
| Prognosis | 1 | 2022 | 2118 | 0.040 |
Why?
| X Chromosome | 1 | 2016 | 13 | 0.040 |
Why?
| Operon | 1 | 2016 | 38 | 0.040 |
Why?
| Ubiquitin Thiolesterase | 1 | 2016 | 23 | 0.040 |
Why?
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 16 | 0.040 |
Why?
| MCF-7 Cells | 1 | 2016 | 79 | 0.030 |
Why?
| Mammals | 1 | 2016 | 57 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2016 | 99 | 0.030 |
Why?
| Ubiquitination | 1 | 2016 | 47 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2016 | 82 | 0.030 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2016 | 41 | 0.030 |
Why?
| Centrifugation | 1 | 2015 | 15 | 0.030 |
Why?
| Middle Aged | 3 | 2020 | 13088 | 0.030 |
Why?
| Reactive Oxygen Species | 1 | 2018 | 491 | 0.030 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 48 | 0.030 |
Why?
| Endopeptidases | 1 | 2016 | 75 | 0.030 |
Why?
| Protein Interaction Maps | 1 | 2015 | 24 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2015 | 73 | 0.030 |
Why?
| RNA Interference | 1 | 2016 | 195 | 0.030 |
Why?
| Isotope Labeling | 1 | 2015 | 58 | 0.030 |
Why?
| Evolution, Molecular | 1 | 2016 | 103 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 186 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2020 | 1693 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 2015 | 252 | 0.030 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2014 | 7 | 0.030 |
Why?
| Open Reading Frames | 1 | 2014 | 55 | 0.030 |
Why?
| Genotype | 1 | 2016 | 599 | 0.030 |
Why?
| Gene Deletion | 1 | 2015 | 293 | 0.030 |
Why?
| Sequence Alignment | 1 | 2014 | 146 | 0.030 |
Why?
| Antibody Specificity | 1 | 2013 | 48 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 94 | 0.030 |
Why?
| Plasmids | 1 | 2014 | 180 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 283 | 0.030 |
Why?
| Pregnancy | 1 | 2021 | 2620 | 0.030 |
Why?
| Antibodies | 1 | 2013 | 178 | 0.030 |
Why?
| Acid Anhydride Hydrolases | 1 | 2012 | 14 | 0.030 |
Why?
| Muscles | 1 | 2013 | 114 | 0.030 |
Why?
| Aged | 2 | 2019 | 10054 | 0.030 |
Why?
| Escherichia coli | 1 | 2014 | 250 | 0.030 |
Why?
| Models, Molecular | 1 | 2013 | 423 | 0.030 |
Why?
| Peptide Fragments | 1 | 2013 | 242 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 2012 | 171 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 474 | 0.030 |
Why?
| Aged, 80 and over | 1 | 2019 | 3431 | 0.020 |
Why?
| Young Adult | 1 | 2020 | 4318 | 0.020 |
Why?
| Retrospective Studies | 1 | 2023 | 6432 | 0.020 |
Why?
| Treatment Outcome | 1 | 2020 | 5604 | 0.020 |
Why?
| Transcriptional Elongation Factors | 1 | 2009 | 28 | 0.020 |
Why?
| Child | 1 | 2022 | 7341 | 0.020 |
Why?
| Epistasis, Genetic | 1 | 2009 | 42 | 0.020 |
Why?
| Recombinant Fusion Proteins | 1 | 2009 | 206 | 0.020 |
Why?
| Adolescent | 1 | 2020 | 6897 | 0.020 |
Why?
| Cohort Studies | 1 | 2013 | 1543 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2009 | 418 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2013 | 847 | 0.020 |
Why?
| Forecasting | 1 | 2007 | 161 | 0.020 |
Why?
| Adult | 1 | 2020 | 14207 | 0.020 |
Why?
|
|
Byrum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|